CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Operating activities
Net income (loss)	$ (2,425)	$ 5,327
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:
Depreciation and amortization	29,515	17,690
Depreciation and amortization - discontinued operations	45	714
Amortization of above market leases	848	1,126
Amortization of below market leases - discontinued operations	0	(32)
Amortization of loan costs	481	537
Share-based compensation expense	89	157
Deferred income tax benefit	(568)	(245)
Gain on sale of real estate investments	(542)	(5,575)
Equity in loss of unconsolidated joint ventures - discontinued operations	0	20
Change in fair value of contingent consideration	0	216
Increase in deferred leasing costs	(2,304)	(1,792)
Changes in operating assets and liabilities:
Change in receivables and other assets	(10,747)	8,468
Change in accounts payable and other liabilities	2,879	(11,045)
Net cash provided by operating activities	17,271	15,566
Investing activities
Distributions from unconsolidated joint ventures	0	120
Investment in real estate	(184,174)	(128,873)
Proceeds from sale of real estate	2,966	110,754
Improvements to real estate	(8,457)	(7,911)
Net cash used in investing activities	(189,665)	(25,910)
Financing activities
Principal payments on mortgage notes payable	(2,385)	(18,033)
Proceeds from mortgage notes payable	164,500	73,500
Proceeds from bank borrowings	28,299	30,126
Payments on bank borrowings	(165,299)	(114,448)
Debt financing costs	(975)	(2,169)
Purchase of Company stock	(35)	(113)
Dividends paid on common stock	(8,380)	(1,657)
Dividends paid on preferred stock	(2,711)	(2,711)
Contributions from noncontrolling interest partners	0	2,731
Distributions to noncontrolling interest partners	(56,863)	(566)
Proceeds from stock offerings, net of transaction costs	208,947	(10)
Net cash provided by (used in) financing activities	165,098	(33,350)
Change in cash and cash equivalents	(7,296)	(43,694)
Cash and cash equivalents at beginning of period	81,856	75,183
Cash and cash equivalents at end of period	$ 74,560	$ 31,489